Laboratory Evaluation of Hypophosphatemia
1. Initial Comprehensive Metabolic Bone Panel
- Order a comprehensive metabolic bone panel (serum phosphate, calcium, creatinine, bicarbonate, 25‑OH vitamin D, 1,25‑(OH)₂ vitamin D, PTH, bone‑specific alkaline phosphatase, and intact FGF23 when available) together with a spot urine for phosphate, calcium, amino acids, glucose, low‑molecular‑weight proteins, and creatinine to calculate TmP/GFR and differentiate renal phosphate wasting, inadequate intake, and FGF23‑mediated disorders. [1][2]
2. Serum Biomarkers and Their Diagnostic Meaning
| Biomarker | Diagnostic Contribution | Key Thresholds / Context |
|---|---|---|
| Serum phosphate | Confirms hypophosphatemia; defined as < 2.5 mg/dL (0.8 mmol/L). In infants, normal‑appearing values may persist for the first 3–4 months despite disease. | Age‑adjusted reference ranges required. |
| Serum calcium | Discriminates etiology: high → primary hyperparathyroidism; low → secondary hyperparathyroidism or vitamin D deficiency; normal → primary renal phosphate wasting. | None specific; interpret relative to phosphate. |
| Serum creatinine & eGFR | Identifies chronic kidney disease, which can cause isolated alkaline phosphatase elevation and hypophosphatemia; necessary for TmP/GFR calculation. | eGFR calculated per standard equations. |
| Serum bicarbonate | Excludes metabolic acidosis as a cause of non‑selective tubular phosphate loss. | Normal bicarbonate rules out acidosis. |
| 25‑OH vitamin D | Screens for vitamin D deficiency, a common cause of hypophosphatemia with secondary hyperparathyroidism. | Deficiency defined per laboratory reference. |
| 1,25‑(OH)₂ vitamin D | Typically low or inappropriately normal in renal phosphate‑wasting disorders; helps separate FGF23‑mediated from non‑FGF23 causes. | None; compare to expected rise in hypophosphatemia. |
| Parathyroid hormone (PTH) | Differentiates PTH‑mediated from non‑PTH hypophosphatemia; upper‑normal or mildly elevated in X‑linked hypophosphatemia, clearly elevated in primary hyperparathyroidism. | Reference range per assay. |
| Alkaline phosphatase (total or bone‑specific) | Elevated in active rickets (children) or osteomalacia (adults); bone‑specific isoform preferred in adults to avoid hepatic confounding. | Elevated values suggest active bone disease. |
3. Urine Biomarkers and Fractional Excretion
- Spot urine phosphate, calcium, and creatinine – collected simultaneously with serum tests to compute TmP/GFR and urinary calcium‑creatinine ratio. 1
TmP/GFR calculation – confirms renal phosphate wasting when fractional phosphate excretion > 15 % in the setting of hypophosphatemia; formula:
Urinary calcium‑creatinine ratio – distinguishes FGF23‑mediated disorders (typically normal/low urinary calcium) from hereditary hypophosphatemic rickets with hypercalciuria. Age‑specific upper limits:
| Age | Upper limit (mol Ca / mol Cr) |
|---|---|
| < 1 yr | 2.2 |
| 1–3 yr | 1.4 |
| 3–5 yr | 1.1 |
| 5–7 yr | 0.8 |
| 7–18 yr | 0.7 |
| > 18 yr | 0.57 |
- 24‑hour urine collection (adults) – provides more accurate calcium and phosphate excretion; upper normal limit for calcium is 0.1 mmol /kg body weight. 1
4. Evaluation for Fanconi (Proximal Tubular) Syndrome
- Urine amino acids, glucose, and low‑molecular‑weight proteins – required to rule out non‑selective proximal tubular phosphate loss (Fanconi syndrome). [1][2]
- Urine bicarbonate and uric acid – also assessed; their loss supports a diagnosis of Fanconi syndrome. [1][2]
5. Advanced Diagnostic Tests
- Intact FGF23 measurement – indicated when family history is negative; elevated or non‑suppressed FGF23 in hypophosphatemia points to FGF23‑mediated disorders (X‑linked hypophosphatemia, tumor‑induced osteomalacia, autosomal hypophosphatemic rickets, or iatrogenic causes such as intravenous iron). [1][2]
- FGF23 interpretation – “low‑normal” levels (> 27 pg/mL on the Immutopics assay) still suggest excess in the presence of low phosphate because FGF23 should be suppressed; assay type (Immutopics vs. Kainos) influences the numeric cut‑off. [1][2]
- Genetic testing – analysis of the PHEX gene (X‑linked hypophosphatemia) or broader panels (DMP1, ENPP1, FGF23, CLCN5, SLC34A3, etc.) confirms the molecular diagnosis when available. [1][2]
6. Medication‑Induced and Acquired Causes
- Intravenous iron preparations (especially ferric carboxymaltose or iron isomaltoside) can precipitate severe FGF23‑mediated hypophosphatemia (“6H‑syndrome”). 1
- Alcohol‑induced FGF23 syndrome – recent evidence shows alcohol directly stimulates FGF23 production, leading to hypophosphatemia. 1
- Acquired etiologies to exclude before attributing genetics – tumor‑induced osteomalacia (new‑onset hypophosphatemia in adults), ectopic FGF23 production in advanced malignancies (e.g., prostate, lung cancer), and primary hyperparathyroidism must be systematically ruled out. [1][2]
Laboratory Evaluation for Hypophosphatemia
Essential Serum Tests
- The American College of Nephrology recommends obtaining serum phosphate, calcium, alkaline phosphatase, parathyroid hormone, 25(OH) vitamin D, 1,25(OH)₂ vitamin D, and creatinine to evaluate hypophosphatemia, with serum phosphate confirming hypophosphatemia (defined as <2.5 mg/dL or 0.8 mmol/L) using age-related reference ranges 3, 4
- Serum calcium is critical for categorizing the etiology of hypophosphatemia, with elevated levels suggesting primary hyperparathyroidism, low levels suggesting secondary hyperparathyroidism or vitamin D deficiency, and normal levels suggesting primary renal phosphate wasting 3, 4
- Alkaline phosphatase (ALP) levels are elevated in active rickets in children or osteomalacia in adults, with bone-specific ALP preferred in adults 3, 5
- Parathyroid hormone (PTH) levels help differentiate PTH-mediated from non-PTH-mediated causes of hypophosphatemia, with levels typically at upper normal range or slightly elevated in X-linked hypophosphatemia 3, 4
- 25(OH) vitamin D is essential to exclude vitamin D deficiency as a cause of hypophosphatemia 3, 4
- 1,25(OH)₂ vitamin D is typically low or inappropriately normal in the setting of hypophosphatemia due to renal phosphate wasting 3, 4
- Creatinine assesses renal function and is needed for TmP/GFR calculation 3, 4
Essential Urine Tests
- A spot urine sample should be obtained for urinary phosphate, calcium, and creatinine to calculate tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR) and urinary calcium:creatinine ratio 3, 4
- TmP/GFR calculation is used to confirm renal phosphate wasting, with fractional phosphate excretion >15% in the presence of hypophosphatemia 3
- In patients with insufficient phosphate intake or impaired intestinal absorption, TmP/GFR can be falsely low until serum phosphate is restored to normal 3, 6
Additional Tests to Exclude Fanconi Syndrome
- To rule out non-selective renal tubular phosphate wasting (Fanconi syndrome), evaluate urine for bicarbonate, amino acids, glucose, and uric acid losses 4, 7
- Low molecular mass proteinuria is also evaluated to exclude Fanconi syndrome 4, 7
Advanced Diagnostic Tests
- Intact FGF23 levels are elevated in FGF23-mediated hypophosphatemia, including X-linked hypophosphatemia and tumor-induced osteomalacia 3, 4
- FGF23 levels are most informative in untreated patients, as levels are influenced by phosphate intake and vitamin D therapy 4, 6
- Genetic testing, such as PHEX gene analysis, confirms X-linked hypophosphatemia when feasible 4, 6
Common Pitfalls
- Age-related reference ranges for serum phosphate levels should be considered, as levels in infants may be normal within the first 3-4 months of life despite underlying disease 4, 6
- Timing of FGF23 measurement is important, as it should be obtained before initiating phosphate or vitamin D therapy for most accurate interpretation 4, 6
Hypophosphatemia Mechanisms in Alcohol Abuse
Renal Phosphate Wasting
- The National Kidney Foundation suggests that proximal tubular defect (Fanconi syndrome) can cause renal phosphate wasting, characterized by concurrent glucosuria, aminoaciduria, and low molecular weight proteinuria 8
FGF23-Mediated Hypophosphatemia
- The American Society of Nephrology notes that alcohol-induced FGF23 syndrome is a recently recognized entity where alcohol directly stimulates FGF23 production, causing renal phosphate wasting, an acquired form of FGF23-related hypophosphatemia 9
- The National Institute of Diabetes and Digestive and Kidney Diseases recommends calculating FEPO4 or TmP/GFR to diagnose renal wasting, and if other causes are excluded, considering FGF23 level, as mediated by FGF23 9
Medication-Induced Hypophosphatemia
- The American Society of Hematology warns that medication-induced hypophosphatemia can occur, for example, if a patient received intravenous iron (especially ferric carboxymaltose), causing severe FGF23-mediated hypophosphatemia 10